Head-to-head · Cost-Efficiency Index
Found vs EdgeRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Found
Insured shoppers willing to prepay 12 months upfront to reach the lowest advertised rate, who also want behavior-change coaching bundled in.
Visit FoundEdgeRx
Men who also want adjacent peptide, longevity, and hormone protocols (MICC, sermorelin, NAD+, PT-141) bundled with GLP-1 on one account.
Visit EdgeRxThe verdict
Found takes it, leading the Cost-Efficiency Index 88 to 74. A real insurance-billing pathway on both molecules — but the widely-quoted $99/mo headline requires an insurance plan AND a full year prepaid upfront; the true no-commitment rate is $199-289/mo. EdgeRx still earns a C — Men who also want adjacent peptide, longevity, and hormone protocols (MICC, sermorelin, NAD+, PT-141) bundled with GLP-1 on one account.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Found.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Found | EdgeRx |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 74/100 |
| Semaglutide / mo | $199/mo (insurance-linked) | $229/mo (once-weekly injectable) |
| Tirzepatide / mo | $199/mo (insurance-linked) | $299/mo (once-weekly injectable) |
| Semaglutide / yr (modeled) | $2,388 | $2,748 |
| Tirzepatide / yr (modeled) | $2,388 | $3,588 |
| Coverage | All 50 states | 46 states — excludes Arkansas, Indiana, Minnesota, South Carolina |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #7 | #45 |
Found
88/100Where the value is
- Genuine insurance-billing pathway, unlike most cash-only compounded competitors — most members reportedly pay under $30/visit
- Nationwide
- Strong behavior-change program adds value
The tradeoffs
- The advertised '$99/mo' headline requires BOTH an insurance-linked plan AND a 12-month prepay at once — the real month-to-month rate is $199/mo (insured) or $289/mo (cash-pay), 2-3x the headline
- Coaching subscription can't be unbundled, which reduces contract flexibility
EdgeRx
74/100Where the value is
- Named Chief Medical Advisor (Dr. John Starke, MD, ABEM board-certified) sets clinical/dosing standards
- Named compounding pharmacy — Strive Pharmacy, a 503A facility operating since 2018
- LegitScript certified, with a specific, named state-exclusion list rather than a vague coverage claim
The tradeoffs
- Men's-only positioning — explicitly not a fit for women readers
- Dr. Starke sets standards but does not personally prescribe; the actual prescribing pool is an unnamed pool of licensed physicians
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.